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Abstract
Bronchopleural fistula (BPF) is a pathological communication between the 
bronchial tree and pleural space. This clinical condition, which has high mortality 
and morbidity, is one of the major therapeutic challenges for clinicians even today. 
BPF may result from a lung neoplasm, necrotizing pneumonia, empyema, blunt 
and penetrating lung injuries, and a complication of surgical procedures. Lung 
resection is the most common cause of BPF, and this chapter will focus more on 
this topic. Frequency ranges from 4.5 to 20% after pneumonectomy and from 0.5 
to 1% after lobectomy. Several risk factors have been defined in the development of 
postoperative BPF; preoperative radiotherapy, pulmonary infection, diabetes, right 
pneumonectomy, a long bronchial stump, residual cancer at the stump (R1 and R2 
resection), and the need for postoperative ventilation (especially with high PEEP). 
BPFs are divided, based on the time elapsed since surgery, into early or late fistula. 
This grouping is important in management of patient treatment. In early BPF, 
surgical treatment is generally the preferred treatment modality, whereas in late 
BPF, conservative approach is preferred. The management of BPF is still one of the 
most complex challenges encountered by the thoracic surgeons; so prevention is the 
best way to manage postoperative BPF.
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1. Introduction
Bronchopleural fistula (BPF) has been defined as a direct communication 
between the bronchus and pleural cavity. Some authors have grouped BPFs as 
central and peripheral according to their locations [1]. While a central BPF defines 
connection between pleura and tracheobronchial three, a peripheral BPF defines 
connection between the pleura and airway distal to segmental bronchi or lung 
parenchyma. In literature, the term of “alveolopleural fistula” is also used to 
describe peripheral BPFs.
Nonsurgical conditions like trauma, chronic necrotizing pneumonia, empyema, 
radiotherapy, bulla, or cyst rupture can cause BPF, but the most common cause is 
lung resection. Frequency ranges from 4.5 to 20% after pneumonectomy and from 
0.5 to 1% after lobectomy. BPF-related mortality ranges from 18 to 71% in the litera-
ture [2–4]. Because of high morbidity and mortality rates, it is important to define 
risk factors and apply preventative methods especially in groups of risky patients.
Many authors have divided postoperative BPFs into two groups according to 
time of onset. There is no consensus about these definitions in the literature, but 
generally, early BPF was defined as fistula occurring within 30 days after the initial 
Diseases of Pleura
2
operation. Late BPF was defined as fistulas occurring after more than 30 days. It is 
established that early BPFs are most commonly associated with a failure in surgical 
technique and mostly, it can be repaired with reoperation [1, 3, 5].
Late BPFs are typically secondary to patient-related factors and almost always 
coexist with empyema, and it usually required complex, long-term, and exhausting 
treatment process for both the patient and the surgeon.
2. Risk factors
BPF is most commonly encountered after lung resections; therefore, estab-
lishing risk factors is important to prevent patients from this highly mortal 
complication.
Numerous risk factors have been associated with BPF development in the litera-
ture [3–6]. We divided these risk factors into three groups: patient-related factors, 
surgeon-related factors, and anatomic factors.
Age (>60), gender (male), neoadjuvant radiation therapy, diabetes mellitus, 
malnutrition, smoking, chronic steroid/immunosuppressive usage, and need for 
postoperative mechanic ventilation can be classified as a patient-related risk factor. 
Induction chemotherapy has been cited as a risk factor for postpneumonectomy 
BPF but there is not any increased risk for bronchoplastic procedures.
A large number of studies have reported an increased risk for BPF due to post-
operative mechanical ventilation usage after pneumonectomy. Therefore, to prevent 
bronchial stump from barotrauma extubation must be achieved at the earliest time 
after surgery.
A low forced expiratory volume in 1 second and low carbon monoxide diffusing 
capacity were also defined as risk factors for postoperative BPF occurrence.
Besides these patient-related risk factors, several anatomic disadvantages were 
defined for right-sided pneumonectomy:
i. According to cadaveric studies, presence of two left-sided and one right-
sided bronchial artery supply is the most common configuration.
ii. While the left main bronchus is protected under the aortic arch and sur-
rounded by mediastinal tissue, the right bronchial stump has no such coverage.
iii. The right main bronchus is wider, and more vertical than the left main 
bronchus. This condition facilitates secretion retention on the right main 
bronchial stump.
Early BPFs are usually related with technical failure during surgery. The most 
common causes of this condition are poorly secured knots, stapler misfiring, and 
high anastomotic tension. Other surgeon-related risk factors are extensive medias-
tinal lymphadenectomy and peribronchial dissection, long bronchial stump and not 
coverage the bronchial stump with viable tissue.
3. Clinical presentations and diagnosis
The size and the time of occurrence of the BPF are major determinants of the 
clinical presentation but, patients often have infection-related symptoms like: fever, 
cough with serosanguinous or purulent sputum, night sweats, and chills.
3Bronchopleural Fistula: Causes, Diagnoses and Management
DOI: http://dx.doi.org/10.5772/intechopen.88127
Expectoration and respiratory symptoms typically worsen with the patient 
lying on the side opposite to the one involving the fistula. Flooding of the infected 
contents of the pleural space to the contralateral lung can lead to severe pneumonia 
or respiratory distress syndrome.
If the patient has a chest tube massive and prolonged air leakage would be an 
important clinical clue for BPF.
White blood cell count and systemic inflammation markers are often elevated.
Chest radiogram often revealed a decrease in the fluid level and enlargement 
in the ipsilateral pleural cavity. Due to the contamination of the contralateral 
lung by the infected content of the pleural cavity, parenchymal infiltration can 
be seen.
Computed tomography of the chest can depict mediastinal emphysema, 
parenchymal infiltration, and enlargement of the pleural cavity, but its success 
at demonstrating the presence of the BPF is controversial. By the imaging of the 
continuation of a bronchus or the lung parenchyma to the pleural space, definitive 
diagnosis of the fistula can be made (Figures 1 and 2). Westcott et al. reported 
sensitivity of the chest CT as 50% at demonstrating the presence of the peripheral 
BPFs. Seo et al. reported that chest CT succeed to demonstrate direct or indirect 
signs of BPF 86% of the patients with central, and 100% of the patients with 
peripheral BPFs [7, 8].
In the presence of clinical or radiological suspicion of BPF, bronchos-
copy must be applied to examine the bronchial stump. Presence of pleural 
fluid leakage or/and air bubbling in the bronchial stump is pathognomonic 
(Figures 3 and 4).
Reconstruction of 2-dimensional, helical CT images provides noninvasive 
intraluminal evaluation of the bronchus named as “virtual bronchoscopy” [9]. 
This technique can provide additional benefits, especially, planning endobronchial 
instrumentation, but it is not an essential diagnostic method of fistula.
Less frequently 133xenon or 99technetium ventilation scintigraphy can be used 
to identify BPF by visualization of the radioactive isotopes in the empty pleural 
cavity. Mark et al. used 99technetium ventilation scintigraphy in 28 postpneumo-
nectomy patients for the detection of BPF and reported sensitivity of 78% and a 
specificity of 100% [10, 11]. Although, this is a noninvasive diagnostic procedure, 
it is not practical and easy-to-use, and has no additional benefit to the detection of 
underlying lung disease.
Figure 1. 
Left sided BPF is seen in the Chest CT. BPF may not always be as clear as this CT image.
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Figure 4. 
Bronchoscope view of the right-sided BPF (arrow) (Asterix shows the main carina).
Figure 2. 
Another chest CT image shows right sided BPF. Chest CT also allows the examination of the remaining lung for 
possible pneumonic infiltrations and metastases.
Figure 3. 
Bronchoscope view of the left-sided BPF (arrow) (Asterix shows the main carina). In bronchoscopy, the fistula 
patency may not always be clearly seen. Air bubbles originating from the stump of the bronchus may be the only 
sign of the BPF.
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4. Management
The management of the BPF needs prolonged hospitalization, complex surgical 
procedures, and close follow-up, but first step in the treatment is management of the 
life-threatening conditions like sepsis, tension pneumothorax, and respiratory failure. 
Protection of the contralateral lung from aspiration of the pleural fluid is important 
to reduce the risk of pneumonia and respiratory failure. Therefore, chest tube must be 
applied to ensure the drainage of the pleural cavity. Broad spectrum antibiotic therapy 
against Gram-Positive, Gram-Negative, and anaerobic microorganisms must be initi-
ated, and it should be tailored based on the results of culture-antibiograms.
Early BPFs are mostly associated with failure in the surgical technique. 
Repairment of the bronchial stump with re-operation is the best treatment modality 
in these patients.
Patients with late BPF mostly have poor medical condition and major surgical 
approaches cannot be applied. Conservative treatment modalities like drainage 
and reduction of the pleural space, pleural irrigation, antibiotics, and nutritional 
supplementation. Boudaya et al. reported their experience with conservative 
management of postresectional BPF in 17 patients and BPF is successfully closed 
in 16 patients [12].
Various endoscopic techniques for the control of small BPFs have been reported, 
especially in patients with poor condition. Sealants, fibrin glue, coils, and endo-
bronchial silicon or metal stents have been used to treat small BPFs (ranging from 
0.8 to 1.0 mm). Dutau et al. used self-expanding metal stents in seven patients with 
large fistulas (>6 mm) and reported improvement in patients’ respiratory param-
eters in early postoperative period [13].
4.1 Surgical interventions for infection control
Besides conservative treatments, several surgical procedures to treat BPFs 
have been defined in the literature. Main objectives in these surgical interven-
tions are debridement of the pleural space, minimizing the residual pleural 
cavity, closure of the fistula, and reinforcement of the bronchial stump with 
autologous tissue.
There are several factors in choosing the appropriate surgical method:
1. Medical condition of the patient
2. Time of onset of the fistula
3. Size and localization of the fistula
4. State of the pleural cavity
4.1.1 Video-assisted thoracoscopic surgery (VATS)
In the presence of pleural infection together with the fistula, tube-thoracostomy 
must be applied in all cases. Pleural irrigation with antibiotic and povidone-iodine 
solutions is suggested in sterilization of the infected postpneumonectomy pleural 
cavity but this treatment modality alone cannot provide sufficient debridement, 
especially in patients with late fistulas and cause prolong hospitalization.
VATS is a useful method to obtain drainage and debridement of the infected 
pleural cavity. Single port is usually sufficient in most cases; material and debris 
can be safely removed with surgical instruments and in the presence of small BPFs 
(<3 mm) fibrine glue can be applied. Hollaus et al. applied videothoracoscopic 
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debridement in nine patients and defined it as an efficient method to treat post-
pneumonectomy empyema [14]. Gossot et al. reported series of 11 patients with 
postpneumonectomy empyema. These 11 patients underwent videothoracoscopic 
debridement and 8 of 11 patients discharged without need of additional surgical 
procedures [15]. These similar studies have shown that VATS is a feasible option for 
treatment in select patients with PPE and small BPF.
4.1.2 Open window thoracostomy
In the presence of empyema drainage of the pleural cavity is essential to control 
the septic status of the patient. Different kinds of drainage techniques were defined 
in the literature. Open-window thoracostomy was first described by Robinson in 
1916 in patients with nontuberculous empyema and Eloesser has revised this proce-
dure for patients with tuberculous empyema [16, 17]. This procedure contains:
1. Segmental resection of 2–3 ribs
2. Creation of a skin flap (Muscle should be preserved if possible)
3. Marsupialization of the cavity
With this procedure, epithelialized thoracostomy window is obtained and effec-
tive drainage is ensured.
After this operation, the wound is packed at least daily with gauze moistened 
with normal saline. Granulation tissue in the wound begins to form over time and 
when the pleural space is clean closure of the window can be considered.
It is very important to have a good cooperation with patient and relatives for this 
treatment modality and they should be informed that this treatment procedure may 
require several weeks.
4.1.3 Clagett procedure
Clagett and Geraci described a two-step treatment technique for the manage-
ment of postpneumonectomy empyema in 1963 [18]. Step 1 contains the open 
window thoracostomy to drain the septic cavity. Step 2 contains obliteration of 
the pleural cavity with antibiotic solution. Pairolero and Arnold has modified this 
procedure and described transposition of a well-vascularized extrathoracic muscle 
as an intermediate step [19]. With this modification, further reinforcement of the 
bronchial stump was ensured.
Clagett procedure shows a success rate (OWT closed without PPE recurrence) of 
61–89% with a mortality rate between 0 and 24% in the literature.
4.2 Surgically closure of a bronchopleural fistula
Large BPF can cause loss in the tidal volume, aspiration of infected pleural fluid, and 
respiratory distress. Therefore, bronchial defect must be controlled, especially in patients 
with large fistulas, for this purpose, two major approaches were defined in the literature.
4.2.1 Transpleural approach
Transpleural approach is the most common method to closure of the BPF 
(Figure 5). First, BPF must be identified. By careful dissection, bronchus must be 
mobilized as close to the carina as possible to provide adequate length. Aggressive 
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dissection and devascularization of the proximal bronchus should be avoided because 
of the risk of failure of the repair and recurrence of BPF. Stapler devices can be used 
if there is a sufficient length in the bronchial stump. Manual suturation also can be 
applied above the BPF. After repairment, bronchial stump must be buttressed with 
well-vascularized tissue such as extrathoracic muscle, omentum, or diaphragm flap.
4.2.2 Transsternal transpericardial approach
In some cases, surgical management of BPF may be challenging through a lateral 
transpleural approach. Presence of short bronchial stumps, left-sided BPF, necrotic 
bronchial stumps and/or history of prior BPF closures via thoracotomy are the main 
reasons that make transpleural approach difficult. In these cases, transsternal trans-
pericardial approach would be a good alternative to transpleural approach [20, 21]. 
This approach provides work in healthy, inflammation-free planes. Therefore, in 
this technique, isolation of the airway is easier and safer than others. Biggest benefit 
of this technique is that it provides the opportunity to work in a healthy plane. 
Retraction of the superior vena cava and aorta laterally provide sufficient exposure to 
make a successful repairment. It is also possible to achieve transpericardial approach 
by anterior thoracic incision with division of multiple costal cartilages which was 
described by Padhi and Lynn [22]. This approach was found to be a difficult and com-
plicated compared to transsternal approach. Therefore, transsternal transpericardial 
approach has become more widely used among surgeons in the repairment of BPF.
4.2.3 Thoracoplasty
One of the major concerns in the treatment of the BPF is obliteration of the per-
sistent space after control of pleural infection. Thoracoplasty is originally considered 
as a treatment for active tuberculosis but this procedure is also functional for obliter-
ate pleural space with the viable tissue of the chest wall in the cases of BPF. This is 
achieved by resection of multiple ribs. Traditional thoracoplasty requires removal of 
the first 11 ribs periosteum, and intercostal muscles with associated neurovascular 
bundles. After removal of these structures, skin and thoracic muscles fill the pleural 
cavity. As can be expected, this procedure has high mortality and morbidity rates 
and is now abandoned. Removing fewer than five ribs named as “tailored” thoraco-
plasty is still in use especially in the treatment of chronic BPFs [23, 24].
It would be rational to use these treatment modalities in combination to deal 
with space problem. Tailored thoracoplasty, muscle transposition, omentoplasty, 
Figure 5. 
Image of the left thoracic cavity of the patient with BPF and empyema. Pleural debris and plaques covering the 
chest wall are seen (Asterix). Infected vascular stumps also are seen (arrow).
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Figure 7. 
Left-sided BPF was closed with customized silicone stent. After this procedure, air drainage from the chest tube 
was decreased and respiratory condition of the patient was improved.
and diaphragm flabs can be used and combined with each other. Clinical condition 
and performance status of the patient are also important for selection of the best 
method in the treatment of BPF.
5. Bronchoscopic management of BPF
Various endoscopic techniques like bronchoscopic application of sealants, fibrin 
glue, silver nitrate cautery, coils, and endobronchial stents for the control of small 
BPFs have been reported [25–29]. There is no consensus on which method is most 
effective for BPF closure. We use endoscopic techniques only for the patients with 
poor clinical condition and not for proper major surgical intervention. Proper 
technique must be selected depending on the length of the bronchial stump, the 
location, and size of the fistula (Figures 6 and 7).
Figure 6. 
Image of the customized (closed in one side with a stapler) silicone stent.
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We often prefer metallic J-stents and silicon Y-stents (Figure 8). The most seen 
complication of these stents is migration and occlusion with secretion. Migration and 
occlusion of the stent can cause severe respiratory distress. Retention of the secretion 
can also cause contamination of the remaining lung and resulted in severe pneumonia.
Despite these complications, in selected patients, endobronchial stents can 
reduce air leakage and prevent remaining lung from contamination with pleural 
fluid.
6.  Prevention of bronchopleural fistula in pulmonary resection-
bronchial stump coverage
To prevent postpneumonectomy bronchopleural fistula, coverage of the bron-
chial stump is recommended, especially for patients with high risk of BPF.
Pedicled intercostal and extrathoracic muscles, diaphragm, pericardium, 
pericardial fat pad, and pleura can be used to make a flap to coverage the bronchial 
stump [30–32]. There is no consensus for best bronchial stump coverage method 
and related techniques with several complications were defined in the literature. 
Figure 8. 
Bronchoscope image of the right-sided BPF. It was closed with self-expandable metallic stent.
Figure 9. 
Pericardial fat pad (Asterix) is very useful material to coverage of the bronchial stump. It is dissected from 
surrounding tissues by preserving the vascular pedicle. Once the fat pad has been mobilized, it is then rotated 
over the hilum to cover the bronchial staple line (arrows).
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Diaphragm flaps can cause visceral herniation. The pedicled intercostal muscle flap 
is useful method for coverage of the bronchial stump but developing heterotopic 
ossification can cause severe problems. Omentum is a great tissue to promote 
re-vascularization and healing of the bronchial stump but it requires the opening 
of the abdominal cavity [33]. Pericardial fat pad coverage appears to be safe and 
feasible when compared with other coverage techniques (Figures 9 and 10). It can 
be applied without risk of additional comorbidity and composes a mechanical bar-
rier between bronchial stump and pleural cavity.
7. Conclusion
In modern thoracic surgery, bronchopleural fistula is still associated with sig-
nificant morbidity and mortality. Treatment techniques have evolved and there are 
many options to use in patients with BPF, therefore surgeon must evaluate clinical 
status of the patient, the size, and location of the BPF and the status of the pleural 
cavity to select the treatment method that will show the most benefit.
It is important to remember that the best treatment is to prevent the disease. 
Therefore, rigorous surgical technique and bronchial stump coverage are the main 
steps in the treatment.
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Appendices and nomenclature
BPF bronchopleural fistula
CT computed tomography
VATS video-assisted thoracoscopic surgery
Figure 10. 
The view of the thoracic cavity after coverage of the left main bronchial stump.
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